A gut–liver axis in intestinal stem cell fitness

Katrina Ray
DOI: https://doi.org/10.1038/s41575-024-00910-7
2024-02-15
Nature Reviews Gastroenterology & Hepatology
Abstract:New research demonstrates that the gut–liver axis plays a part in calibrating intestinal stem cell (ISC) expansion during intestinal homeostasis in mice, with a key role for the hepatokine pigment epithelium-derived factor (PEDF). In a series of experiments using transcriptomics, proteomics and hepatectomy in mouse models, the researchers identified PEDF, a liver-derived soluble WNT inhibitor, which restrained ISC proliferation, maintaining intestinal homeostasis by suppressing the WNT–β-catenin signalling pathway (via LRP5/6). Moreover, the gut–liver axis was involved in PEDF production. Microbial danger signals (lipopolysaccharide) could be sensed by the liver, inhibiting the production of PEDF via liver-derived peroxisome proliferator-activator receptor-α (PPARα). This step allowed ISC proliferation to accelerate tissue repair in the gut after damage to the intestinal epithelium due to colitis. Crucially, treatment of mice with fibrofenate (a PPARα agonist) increased susceptibility to colitis in mouse models via PEDF.
gastroenterology & hepatology
What problem does this paper attempt to address?